Chinese expert consensus recommendations for management of genitourinary syndrome of menopause in women with breast cancer (version 2024)
10.3760/cma.j.cn115807-20240326-00087
- VernacularTitle:中国女性乳腺癌患者绝经生殖泌尿综合征管理专家共识（2024年版）
- Keywords:
Breast cancer;
Genitourinary syndrome of menopause;
Breast cancer recurrence risk
- From:
Chinese Journal of Endocrine Surgery
2024;18(3):317-329
- CountryChina
- Language:Chinese
-
Abstract:
Genitourinary syndrome of menopause (GSM) is more prevalent among breast cancer patients, with a notable absence of timely and effective diagnosis and treatment, severely impacting patients' quality of life and prognosis. With the improved survival rates of breast cancer patients, the management of cancer has entered an era of chronic disease management. However, there is still a lack of targeted guidelines or consensus for the management of GSM in women with breast cancer in China. Based on the guideline/expert consensus and the clinical experience of multiple medical centers, Breast Surgery Expert Working Group of Surgeons Branch of Chinese Medical Doctor Association, the Society of Clinical Cancer Research Administration of China Anti-Cancer Association, the Breast Cancer Expert Committee of the National Cancer Quality Control Center, Breast Cancer Rehabilitation Committee of China Anti-Cancer Association, Chongqing Federation of Clinical Medical Research, the Society of Onco-endocrinology of Chongqing Anti-Cancer Association, Obstetrics and Gynecology Committee of Chongqing Medical Association, Chongqing Sexology Association, Committee of Urology of Chongqing Medical Association, and Chongqing Maternal and Child Health Association thoroughly discussed and formulated the Chinese expert consensus recommendations for management of genitourinary syndrome of menopause in women with breast cancer (version 2024), in order to further standardize the management of GSM in breast cancer patients.
